Tamiflu and Vancomycin hcl drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Tamiflu (oseltamivir phosphate) and Vancomycin hcl (vancomycin hydrochloride). Common drug interactions include arthralgia among females and acute respiratory distress syndrome among males.

The phase IV clinical study analyzes what interactions people have when they take Tamiflu and Vancomycin hcl. It is created by eHealthMe based on reports of 21 people who take the same drugs from the FDA, and is updated regularly.

What is Tamiflu?

Tamiflu has active ingredients of oseltamivir phosphate. It is often used in the flu. eHealthMe is studying from 22,209 Tamiflu users. Check the latest studies of Tamiflu.

What is Vancomycin hcl?

Vancomycin hcl has active ingredients of vancomycin hydrochloride. It is often used in clostridium difficile colitis. eHealthMe is studying from 6,530 Vancomycin hcl users. Check the latest studies of Vancomycin hcl.



On Jul, 09, 2026

21 people who take Tamiflu and Vancomycin hcl together, and have interactions are studied.

Tamiflu and Vancomycin hcl drug interactions.

What are the common drug interactions of Tamiflu and Vancomycin Hcl, by gender? *:

female:

  1. Arthralgia (joint pain)
  2. Blepharitis (chronic inflammation of the eyelid)
  3. Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
  4. Conjunctival hyperaemia (congestion of conjunctival vessels)
  5. Emotional distress
  6. Myalgia (muscle pain)
  7. Pharyngeal erythema (pharyngeal redness)
  8. Rash erythematous (redness of the skin)
  9. Rash pruritic (redness with itching)
  10. Skin erosion (a discontinuity of the skin)

male:

  1. Acute respiratory distress syndrome
  2. Cardiac failure
  3. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
  4. Emotional distress
  5. Injury
  6. Neuropathy peripheral (surface nerve damage)
  7. Pain
  8. Rash morbilliform (a rash that looks like measles)
  9. Renal failure (kidney dysfunction)
  10. Sepsis (a severe blood infection that can lead to organ failure and death)

What are the common drug interactions of Tamiflu and Vancomycin Hcl, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

  1. Acute respiratory distress syndrome
  2. Cardiac failure
  3. Hepatocellular injury (liver injury)
  4. Peritonitis (inflammation of the peritoneum, the thin tissue that lines the inner wall of the abdomen and covers most of the abdominal organs)
  5. Pneumothorax (the presence of air or gas in the cavity between the lungs and the chest wall, causing collapse of the lung)
  6. Respiratory failure (inadequate gas exchange by the respiratory system)
  7. Thrombocytopenia (decrease of platelets in blood)
  8. Electrocardiogram qt prolonged
  9. Abdominal pain
  10. Blood disorder

10-19:

  1. Arthralgia (joint pain)
  2. Burning sensation
  3. Muscle spasms (muscle contraction)
  4. Muscular weakness (muscle weakness)
  5. Neuropathy peripheral (surface nerve damage)
  6. Pain in extremity
  7. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)

20-29:

n/a

30-39:

  1. Death

40-49:

  1. Rash morbilliform (a rash that looks like measles)
  2. Sepsis (a severe blood infection that can lead to organ failure and death)
  3. Staphylococcal sepsis (blood infection by an infection with staphylococcus bacteria)
  4. Toxic epidermal necrolysis (a rare, life-threatening skin condition that is usually caused by a reaction to drugs causes wide spread skin destruction)
  5. Cerebral infarction (less blood supply to brain resulting tissue damage)
  6. Death
  7. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  8. Lung infiltration (a substance that normally includes fluid, inflammatory exudates or cells that fill a region of lung)
  9. Respiratory failure (inadequate gas exchange by the respiratory system)
  10. Respiratory syncytial virus infection (viral disease of respiratory system)

50-59:

  1. Antibiotic level above therapeutic
  2. Drug ineffective

60+:

  1. Emotional distress
  2. Arthralgia (joint pain)
  3. Skin exfoliation (removal of the oldest dead skin cells)
  4. Tachypnoea (a condition of rapid breathing over 20 per minute)
  5. Toxic epidermal necrolysis (a rare, life-threatening skin condition that is usually caused by a reaction to drugs causes wide spread skin destruction)
  6. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  7. Anxiety
  8. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
  9. General physical health deterioration (weak health status)
  10. Injury

What are the existing conditions these people have? *

  1. Pain: 4 people, 19.05%
  2. Nausea (feeling of having an urge to vomit): 4 people, 19.05%
  3. Multiple Myeloma (cancer of the plasma cells): 3 people, 14.29%
  4. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 14.29%
  5. Stress And Anxiety: 2 people, 9.52%
  6. Respiratory Tract Infection: 2 people, 9.52%
  7. Overgrowth Bacterial (extra growth due to bacteria): 2 people, 9.52%
  8. Neurogenic Bladder (the normal function of the bladder is to store and empty urine in a coordinated, controlled fashion): 2 people, 9.52%
  9. Juvenile Arthritis (arthritis-related condition that develops in children or teenagers): 2 people, 9.52%
  10. Embolism (obstruction of an artery, typically by a clot of blood or an air bubble): 2 people, 9.52%

* Approximation only. Some reports may have incomplete information.

Do you take Tamiflu and Vancomycin hcl?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Tamiflu and Vancomycin hcl:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Tamiflu:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Vancomycin hcl:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Tamiflu and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Vancomycin hcl and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on oseltamivir phosphate and vancomycin hydrochloride (the active ingredients of Tamiflu and Vancomycin hcl, respectively), and Tamiflu and Vancomycin hcl (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: